Sign In
Buy MKGAF
$149.28
-7.84 (-4.99%)
At Close: Jun 22, 2026
DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Center for Drug Evaluation (CDE) of the China National Medical P
Merck KGaA (MKGAF) Q1 2025 Earnings Call Transcript
04:53pm, Thursday, 15'th May 2025
Merck KGaA (OTCPK:MKGAF) Q1 2025 Earnings Call May 15, 2025 8:00 AM ET Company Participants Florian Schraeder - Head, Investor Relations Belen Garijo - Group Chief Executive Officer Helene von Roeder
Germany's Merck drops China surcharge on orders after US-China tariff deal
08:46am, Wednesday, 14'th May 2025
German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China following the U.S.-China agreement to pause sky-high tariffs on each other, the com
Merck KGaA swoops for US group SpringWorks in $3.4bn deal
02:58am, Monday, 28'th Apr 2025
Germany's Merck KGaA has agreed to acquire US biotech firm SpringWorks Therapeutics for $3.9 billion in cash. The deal, announced on Monday, values SpringWorks at $47 a share and reflects an enterpri
Germany's Merck Set to Buy SpringWorks in $3.9 Billion Deal
02:33am, Monday, 28'th Apr 2025
The deal to acquire the U.S. biopharmaceutical company confirms an earlier report in The Wall Street Journal.
Germany's Merck KGaA in $3.9 bln deal to acquire US biotech firm SpringWorks
02:21am, Monday, 28'th Apr 2025
German healthcare and materials group Merck KGaA said on Monday it struck a deal to acquire U.S. biotech firm SpringWorks Therapeutics for an equity value of $3.9 billion to boost its cancer drug busi
Resilience is part of our DNA, says Merck KGaA CEO
01:00pm, Thursday, 06'th Mar 2025
Belén Garijo, CEO of Merck KGaA, said the German pharmaceutical company has increased its readiness to deal with the ongoing geopolitical uncertainty, and is confident it will continue delivering pro
Merck KGaA (MKGAF) Q4 2024 Earnings Call Transcript
12:34pm, Thursday, 06'th Mar 2025
Merck KGaA (OTCPK:MKGAF) Q4 2024 Results Conference Call March 6, 2025 8:00 AM ET Company Participants Florian Schraeder - Head of Investor Relations Belen Garijo - Group CEO Helene von Roeder - Group
Merck KGaA sees forex-adjusted earnings growth of up to 8% this year
01:09am, Thursday, 06'th Mar 2025
Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor chemicals and for lab equipment in biotech drug production.
Exclusive: Germany's Merck KGaA in talks to buy US cancer biotech firm Springworks, sources say
09:50am, Monday, 10'th Feb 2025
Merck KGaA , the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker Springworks Therapeutics , according to people familiar with the matter
Merck KGaA says high asset prices call for prudent M&A approach
09:39am, Thursday, 23'rd Jan 2025
The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious approach when it comes to buying other companies, which are expensively priced.
Is Merck KGaA (MKKGY) Stock Undervalued Right Now?
10:40am, Wednesday, 27'th Nov 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Merck KGaA (MKGAF) Q3 2024 Earnings Call Transcript
03:29pm, Thursday, 14'th Nov 2024
Merck KGaA (OTCPK:MKGAF) Q3 2024 Earnings Conference Call November 14, 2024 8:00 AM ET Company Participants Constantin Fest - Head of Investor Relations Belen Lopez - Chair of Executive Board & CEO He
Is Merck KGaA (MKKGY) a Great Value Stock Right Now?
10:45am, Monday, 11'th Nov 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
AI is driving semiconductor industry, says CEO Electronics at Merck KgaA
11:14pm, Sunday, 20'th Oct 2024
Kai Beckmann, a member of the executive board and the CEO Electronics at Merck KgaA, discusses the use of AI in the semiconductor industry.
